If you’re living with advanced kidney disease, preparing for dialysis can feel overwhelming. One crucial decision is how your blood will be accessed for treatment. While there are different options, ...

In a related press release, lead author Gerald A. Beathard, MD, PhD, of the University of Texas Medical Branch, said, “The dramatic difference in durability between the endovascular fistulas and the ...

A new study shows that for those individuals with chronic kidney disease, it doesn't matter if you're young or old: arteriovenous (AV) fistulas remain the gold standard for maintaining access to one's ...

The successful creation and use of arteriovenous fistulas (AVFs) for vascular access for dialysis patients varies considerably between countries, despite national guidelines that uniformly recommend ...

Amplifi Vascular, developer of the first-of-its-kind Vein Dilation System designed to increase eligibility, improve creation ...

Pilot study reveals AV fistula can increase cardiac output and dilation of all heart chambers. Study of AV fistula using cardiovascular MRI reveals increased cardiac output, dilation of heart chambers ...

Among older patients undergoing hemodialysis, outcomes achieved with fistulas vs. grafts vary significantly by race/ethnicity, according to recent findings. In the study, researchers reviewed Medicare ...

In a study, vonapanitase did not improve primary patency compared with placebo, but did improve secondary patency and fistula use for hemodialysis. ORLANDO, Fla.—Vonapanitase, an investigational drug ...

NEW ORLEANS — With the help of nanotechnology, interventionalists might soon be able to create an immediate and permanent percutaneous arteriovenous fistula that has patency and maturation rates ...

CRESSKILL, NJ / ACCESSWIRE / August 5, 2024 / Vascular Therapies, a biotechnology company focused on improving vascular access outcomes in patients with kidney disease, today announced completion of ...